

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.10921383 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.10921383 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.80261090 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.80261090 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.36043484 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.03633143 |
| 7 | regulation of apoptotic cell clearance (GO:2000425) | 5.95403044 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.73066746 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.73066746 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.73066746 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.67405734 |
| 12 | exogenous drug catabolic process (GO:0042738) | 5.63602759 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.62323999 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 5.61943169 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 5.56780854 |
| 16 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.55129709 |
| 17 | complement activation, alternative pathway (GO:0006957) | 5.51471751 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.45468424 |
| 19 | regulation of protein activation cascade (GO:2000257) | 5.44200548 |
| 20 | tryptophan metabolic process (GO:0006568) | 5.41086319 |
| 21 | urea cycle (GO:0000050) | 5.39126353 |
| 22 | urea metabolic process (GO:0019627) | 5.39126353 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.33459026 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.33121985 |
| 25 | protein carboxylation (GO:0018214) | 5.33121985 |
| 26 | regulation of humoral immune response (GO:0002920) | 5.28822286 |
| 27 | high-density lipoprotein particle remodeling (GO:0034375) | 5.25571503 |
| 28 | cysteine metabolic process (GO:0006534) | 5.22601331 |
| 29 | intestinal cholesterol absorption (GO:0030299) | 5.15516178 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 5.15308921 |
| 31 | regulation of complement activation (GO:0030449) | 5.10021195 |
| 32 | negative regulation of complement activation (GO:0045916) | 5.04598958 |
| 33 | omega-hydroxylase P450 pathway (GO:0097267) | 4.99791642 |
| 34 | regulation of plasminogen activation (GO:0010755) | 4.94736456 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 4.93854893 |
| 36 | protein-lipid complex assembly (GO:0065005) | 4.81775899 |
| 37 | reverse cholesterol transport (GO:0043691) | 4.80431057 |
| 38 | bile acid metabolic process (GO:0008206) | 4.80134398 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.79430319 |
| 40 | regulation of triglyceride catabolic process (GO:0010896) | 4.73684544 |
| 41 | serine family amino acid catabolic process (GO:0009071) | 4.70438440 |
| 42 | plasma lipoprotein particle organization (GO:0071827) | 4.63915390 |
| 43 | regulation of cholesterol esterification (GO:0010872) | 4.60223785 |
| 44 | aromatic amino acid family metabolic process (GO:0009072) | 4.58639609 |
| 45 | homocysteine metabolic process (GO:0050667) | 4.56045140 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.55673122 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.55673122 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.55673122 |
| 49 | tyrosine metabolic process (GO:0006570) | 4.49853654 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 4.46308060 |
| 51 | negative regulation of hemostasis (GO:1900047) | 4.45863395 |
| 52 | negative regulation of blood coagulation (GO:0030195) | 4.45863395 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.42771029 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.42771029 |
| 55 | phospholipid efflux (GO:0033700) | 4.40606885 |
| 56 | lysine metabolic process (GO:0006553) | 4.39332281 |
| 57 | lysine catabolic process (GO:0006554) | 4.39332281 |
| 58 | protein-lipid complex subunit organization (GO:0071825) | 4.37751707 |
| 59 | positive regulation of blood coagulation (GO:0030194) | 4.33696562 |
| 60 | positive regulation of hemostasis (GO:1900048) | 4.33696562 |
| 61 | plasma lipoprotein particle clearance (GO:0034381) | 4.32960964 |
| 62 | negative regulation of sterol transport (GO:0032372) | 4.31318096 |
| 63 | negative regulation of cholesterol transport (GO:0032375) | 4.31318096 |
| 64 | alpha-amino acid catabolic process (GO:1901606) | 4.29266926 |
| 65 | ethanol metabolic process (GO:0006067) | 4.26381043 |
| 66 | negative regulation of humoral immune response (GO:0002921) | 4.26310146 |
| 67 | ethanol oxidation (GO:0006069) | 4.21294517 |
| 68 | bile acid and bile salt transport (GO:0015721) | 4.16341744 |
| 69 | negative regulation of coagulation (GO:0050819) | 4.11429222 |
| 70 | cellular ketone body metabolic process (GO:0046950) | 4.09789588 |
| 71 | daunorubicin metabolic process (GO:0044597) | 4.09455111 |
| 72 | polyketide metabolic process (GO:0030638) | 4.09455111 |
| 73 | doxorubicin metabolic process (GO:0044598) | 4.09455111 |
| 74 | fibrinolysis (GO:0042730) | 4.07538405 |
| 75 | cholesterol efflux (GO:0033344) | 4.02673329 |
| 76 | indolalkylamine metabolic process (GO:0006586) | 4.02367057 |
| 77 | coenzyme catabolic process (GO:0009109) | 4.02173833 |
| 78 | negative regulation of wound healing (GO:0061045) | 4.00381485 |
| 79 | cellular glucuronidation (GO:0052695) | 3.99373814 |
| 80 | glutamate metabolic process (GO:0006536) | 3.99023274 |
| 81 | positive regulation of coagulation (GO:0050820) | 3.98382193 |
| 82 | cellular amino acid catabolic process (GO:0009063) | 3.95477953 |
| 83 | benzene-containing compound metabolic process (GO:0042537) | 3.92505330 |
| 84 | glycine metabolic process (GO:0006544) | 3.92440991 |
| 85 | cellular biogenic amine catabolic process (GO:0042402) | 3.91571354 |
| 86 | amine catabolic process (GO:0009310) | 3.91571354 |
| 87 | imidazole-containing compound metabolic process (GO:0052803) | 3.90628534 |
| 88 | positive regulation of extracellular matrix organization (GO:1903055) | 3.83076718 |
| 89 | serine family amino acid metabolic process (GO:0009069) | 3.81494119 |
| 90 | plasma lipoprotein particle assembly (GO:0034377) | 3.81435183 |
| 91 | cellular modified amino acid catabolic process (GO:0042219) | 3.81342040 |
| 92 | complement activation, classical pathway (GO:0006958) | 3.78483655 |
| 93 | negative regulation of lipase activity (GO:0060192) | 3.78455325 |
| 94 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.78228431 |
| 95 | low-density lipoprotein particle remodeling (GO:0034374) | 3.77365330 |
| 96 | complement activation (GO:0006956) | 3.76481106 |
| 97 | regulation of bile acid biosynthetic process (GO:0070857) | 3.75047912 |
| 98 | phospholipid homeostasis (GO:0055091) | 3.75036199 |
| 99 | acute-phase response (GO:0006953) | 3.74431770 |
| 100 | acute inflammatory response (GO:0002526) | 3.72367393 |
| 101 | aldehyde catabolic process (GO:0046185) | 3.71598722 |
| 102 | arginine metabolic process (GO:0006525) | 3.71380070 |
| 103 | opsonization (GO:0008228) | 3.71180166 |
| 104 | drug metabolic process (GO:0017144) | 3.71167399 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.71116125 |
| 106 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.69587259 |
| 107 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.69587259 |
| 108 | protein activation cascade (GO:0072376) | 3.69120551 |
| 109 | drug catabolic process (GO:0042737) | 3.68588055 |
| 110 | regulation of cholesterol homeostasis (GO:2000188) | 3.65716245 |
| 111 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.63936266 |
| 112 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.63936266 |
| 113 | lipoprotein metabolic process (GO:0042157) | 3.63232036 |
| 114 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.62136254 |
| 115 | blood coagulation, intrinsic pathway (GO:0007597) | 3.61161622 |
| 116 | cholesterol homeostasis (GO:0042632) | 3.59186083 |
| 117 | regulation of acute inflammatory response (GO:0002673) | 3.57394485 |
| 118 | serine family amino acid biosynthetic process (GO:0009070) | 3.55939067 |
| 119 | negative regulation of protein activation cascade (GO:2000258) | 3.55483925 |
| 120 | acetyl-CoA metabolic process (GO:0006084) | 3.54515159 |
| 121 | cytolysis (GO:0019835) | 3.54356052 |
| 122 | sterol homeostasis (GO:0055092) | 3.54315680 |
| 123 | uronic acid metabolic process (GO:0006063) | 3.54221657 |
| 124 | glucuronate metabolic process (GO:0019585) | 3.54221657 |
| 125 | ketone body metabolic process (GO:1902224) | 3.53227250 |
| 126 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.52923810 |
| 127 | response to nitrosative stress (GO:0051409) | 3.52065957 |
| 128 | epoxygenase P450 pathway (GO:0019373) | 3.50687632 |
| 129 | organic acid catabolic process (GO:0016054) | 3.49396563 |
| 130 | carboxylic acid catabolic process (GO:0046395) | 3.49396563 |
| 131 | cofactor catabolic process (GO:0051187) | 3.46852977 |
| 132 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.46399475 |
| 133 | cholesterol transport (GO:0030301) | 3.41504287 |
| 134 | sterol transport (GO:0015918) | 3.41504287 |
| 135 | primary alcohol catabolic process (GO:0034310) | 3.40672019 |
| 136 | flavonoid metabolic process (GO:0009812) | 3.34741852 |
| 137 | intestinal absorption (GO:0050892) | 3.29557963 |
| 138 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.24194376 |
| 139 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.24016804 |
| 140 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.20322744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.69077576 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.59938319 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.29784151 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.08347383 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.90931186 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.80982314 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.52293722 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.97794343 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.45290681 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.15570693 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08240892 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.8756558 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.97661201 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.95519724 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.83145451 |
| 16 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.77735702 |
| 17 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.71528158 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65228193 |
| 19 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.63998196 |
| 20 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.61533770 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59483945 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.50596125 |
| 23 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50003286 |
| 24 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.48557407 |
| 25 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34576554 |
| 26 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.32327147 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30461691 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30439825 |
| 29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.24989172 |
| 30 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.22862640 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22368454 |
| 32 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.19919251 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.18530945 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16875569 |
| 35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.15464926 |
| 36 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14095679 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.10509833 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10012930 |
| 39 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04368368 |
| 40 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03234913 |
| 41 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03234913 |
| 42 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.03039314 |
| 43 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02956031 |
| 44 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.02806309 |
| 45 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02192245 |
| 46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01261694 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98002295 |
| 48 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.97943199 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97508247 |
| 50 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96090272 |
| 51 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95748940 |
| 52 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94517710 |
| 53 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94343408 |
| 54 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93921170 |
| 55 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.92744479 |
| 56 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91585096 |
| 57 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90745654 |
| 58 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.90541612 |
| 59 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.89173676 |
| 60 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.88249008 |
| 61 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.86500383 |
| 62 | * AR_21909140_ChIP-Seq_LNCAP_Human | 0.86391037 |
| 63 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86309705 |
| 64 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84749311 |
| 65 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84135336 |
| 66 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.84049823 |
| 67 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.81728595 |
| 68 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.81724634 |
| 69 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.81372873 |
| 70 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.80507749 |
| 71 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.80194983 |
| 72 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.79116222 |
| 73 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.78832405 |
| 74 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.77924365 |
| 75 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.77652498 |
| 76 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.77346745 |
| 77 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.77238850 |
| 78 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.75875299 |
| 79 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.75545084 |
| 80 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.73760988 |
| 81 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.73136279 |
| 82 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.72965084 |
| 83 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.72483314 |
| 84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.71012346 |
| 85 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.70222016 |
| 86 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68954202 |
| 87 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.68788057 |
| 88 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.68034832 |
| 89 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.67404592 |
| 90 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67200576 |
| 91 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.65600237 |
| 92 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.65574242 |
| 93 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.65211003 |
| 94 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64657541 |
| 95 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.62692859 |
| 96 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.62497735 |
| 97 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.60872705 |
| 98 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.60363522 |
| 99 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.59616203 |
| 100 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.58688167 |
| 101 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.58650713 |
| 102 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.57959960 |
| 103 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.57177799 |
| 104 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.56602094 |
| 105 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.56223108 |
| 106 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.56062619 |
| 107 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.56047592 |
| 108 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55661404 |
| 109 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.54654339 |
| 110 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.54464921 |
| 111 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.53442377 |
| 112 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.53415199 |
| 113 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.53365879 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.52517947 |
| 115 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52336154 |
| 116 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.52011834 |
| 117 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.51917538 |
| 118 | GATA1_19941826_ChIP-Seq_K562_Human | 0.51395530 |
| 119 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.50297331 |
| 120 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.50297331 |
| 121 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.50139601 |
| 122 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.49867015 |
| 123 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.49695673 |
| 124 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.49552413 |
| 125 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48384591 |
| 126 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46538363 |
| 127 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.46493490 |
| 128 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.46313921 |
| 129 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.45849999 |
| 130 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.45596807 |
| 131 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.45346252 |
| 132 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.44787275 |
| 133 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.44577036 |
| 134 | AR_20517297_ChIP-Seq_VCAP_Human | 0.44514961 |
| 135 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.42981166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.03373796 |
| 2 | MP0005360_urolithiasis | 6.95636378 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.11728655 |
| 4 | MP0005365_abnormal_bile_salt | 5.85217317 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.84671739 |
| 6 | MP0003252_abnormal_bile_duct | 3.93913609 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.92176123 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.46542497 |
| 9 | MP0005083_abnormal_biliary_tract | 3.22699234 |
| 10 | MP0009840_abnormal_foam_cell | 3.09997206 |
| 11 | MP0003195_calcinosis | 2.87640297 |
| 12 | MP0005332_abnormal_amino_acid | 2.61012622 |
| 13 | MP0003122_maternal_imprinting | 2.59439269 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.56847239 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.45403532 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.32073384 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.16878320 |
| 18 | MP0000609_abnormal_liver_physiology | 2.14449321 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.05550745 |
| 20 | MP0000566_synostosis | 1.94206985 |
| 21 | MP0002132_abnormal_respiratory_system | 1.85309256 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.77282955 |
| 23 | MP0003868_abnormal_feces_composition | 1.71953753 |
| 24 | MP0001915_intracranial_hemorrhage | 1.70584773 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.57373758 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.56773917 |
| 27 | MP0003011_delayed_dark_adaptation | 1.53488759 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.47546561 |
| 29 | MP0002254_reproductive_system_inflammat | 1.34991441 |
| 30 | MP0001764_abnormal_homeostasis | 1.34419647 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.29155252 |
| 32 | MP0010368_abnormal_lymphatic_system | 1.24637722 |
| 33 | MP0009697_abnormal_copulation | 1.24039293 |
| 34 | MP0003186_abnormal_redox_activity | 1.22722701 |
| 35 | MP0006054_spinal_hemorrhage | 1.18235953 |
| 36 | MP0002089_abnormal_postnatal_growth/wei | 1.15004147 |
| 37 | MP0000598_abnormal_liver_morphology | 1.14132395 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.13820180 |
| 39 | MP0009764_decreased_sensitivity_to | 1.13748993 |
| 40 | MP0000604_amyloidosis | 1.13198497 |
| 41 | MP0010234_abnormal_vibrissa_follicle | 1.12222843 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.06074356 |
| 43 | MP0005451_abnormal_body_composition | 1.04986663 |
| 44 | MP0009763_increased_sensitivity_to | 1.02599702 |
| 45 | MP0003950_abnormal_plasma_membrane | 1.00062552 |
| 46 | MP0003123_paternal_imprinting | 0.99839555 |
| 47 | MP0005647_abnormal_sex_gland | 0.98503091 |
| 48 | MP0002282_abnormal_trachea_morphology | 0.98066565 |
| 49 | MP0005408_hypopigmentation | 0.90881766 |
| 50 | MP0005409_darkened_coat_color | 0.87505189 |
| 51 | MP0005670_abnormal_white_adipose | 0.87216798 |
| 52 | MP0008469_abnormal_protein_level | 0.86826227 |
| 53 | MP0005084_abnormal_gallbladder_morpholo | 0.86707305 |
| 54 | MP0004130_abnormal_muscle_cell | 0.84493662 |
| 55 | * MP0005636_abnormal_mineral_homeostasis | 0.83997554 |
| 56 | MP0005220_abnormal_exocrine_pancreas | 0.83808237 |
| 57 | MP0009642_abnormal_blood_homeostasis | 0.81736855 |
| 58 | MP0009053_abnormal_anal_canal | 0.78232300 |
| 59 | MP0002933_joint_inflammation | 0.77025081 |
| 60 | MP0003300_gastrointestinal_ulcer | 0.72114462 |
| 61 | MP0003183_abnormal_peptide_metabolism | 0.71894713 |
| 62 | MP0002971_abnormal_brown_adipose | 0.71423558 |
| 63 | MP0009765_abnormal_xenobiotic_induced | 0.71095878 |
| 64 | MP0002078_abnormal_glucose_homeostasis | 0.70718256 |
| 65 | MP0003172_abnormal_lysosome_physiology | 0.69651560 |
| 66 | MP0003329_amyloid_beta_deposits | 0.69105963 |
| 67 | MP0001661_extended_life_span | 0.68831153 |
| 68 | MP0009384_cardiac_valve_regurgitation | 0.68738604 |
| 69 | MP0001881_abnormal_mammary_gland | 0.68599141 |
| 70 | MP0005334_abnormal_fat_pad | 0.68307047 |
| 71 | * MP0005376_homeostasis/metabolism_phenot | 0.66511375 |
| 72 | MP0002928_abnormal_bile_duct | 0.66509734 |
| 73 | * MP0005164_abnormal_response_to | 0.64852499 |
| 74 | MP0003943_abnormal_hepatobiliary_system | 0.63410552 |
| 75 | MP0002909_abnormal_adrenal_gland | 0.63390540 |
| 76 | MP0005248_abnormal_Harderian_gland | 0.62324986 |
| 77 | MP0001756_abnormal_urination | 0.61138763 |
| 78 | MP0003879_abnormal_hair_cell | 0.61010962 |
| 79 | MP0002168_other_aberrant_phenotype | 0.59623083 |
| 80 | MP0005395_other_phenotype | 0.59221654 |
| 81 | MP0005377_hearing/vestibular/ear_phenot | 0.58266552 |
| 82 | MP0003878_abnormal_ear_physiology | 0.58266552 |
| 83 | MP0002796_impaired_skin_barrier | 0.57040689 |
| 84 | MP0005666_abnormal_adipose_tissue | 0.56866932 |
| 85 | MP0002060_abnormal_skin_morphology | 0.56841246 |
| 86 | MP0005257_abnormal_intraocular_pressure | 0.56759566 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.56642801 |
| 88 | MP0002876_abnormal_thyroid_physiology | 0.56361395 |
| 89 | MP0003724_increased_susceptibility_to | 0.56085080 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 0.55745740 |
| 91 | MP0005464_abnormal_platelet_physiology | 0.54763727 |
| 92 | MP0000639_abnormal_adrenal_gland | 0.53793977 |
| 93 | MP0008438_abnormal_cutaneous_collagen | 0.53646354 |
| 94 | MP0005023_abnormal_wound_healing | 0.53183549 |
| 95 | MP0004782_abnormal_surfactant_physiolog | 0.52917938 |
| 96 | MP0003075_altered_response_to | 0.51773595 |
| 97 | MP0005166_decreased_susceptibility_to | 0.50958772 |
| 98 | MP0005187_abnormal_penis_morphology | 0.50534266 |
| 99 | MP0005535_abnormal_body_temperature | 0.50193099 |
| 100 | * MP0003632_abnormal_nervous_system | 0.49730228 |
| 101 | MP0005275_abnormal_skin_tensile | 0.49178683 |
| 102 | MP0003453_abnormal_keratinocyte_physiol | 0.48978959 |
| 103 | MP0000579_abnormal_nail_morphology | 0.48900402 |
| 104 | MP0005266_abnormal_metabolism | 0.48853051 |
| 105 | MP0001270_distended_abdomen | 0.48670182 |
| 106 | MP0005076_abnormal_cell_differentiation | 0.48432182 |
| 107 | MP0004043_abnormal_pH_regulation | 0.48427028 |
| 108 | MP0002128_abnormal_blood_circulation | 0.46742358 |
| 109 | MP0004264_abnormal_extraembryonic_tissu | 0.46609417 |
| 110 | MP0002295_abnormal_pulmonary_circulatio | 0.45926255 |
| 111 | MP0000858_altered_metastatic_potential | 0.45580600 |
| 112 | MP0003638_abnormal_response/metabolism_ | 0.45511380 |
| 113 | MP0005448_abnormal_energy_balance | 0.44838067 |
| 114 | * MP0003690_abnormal_glial_cell | 0.44520367 |
| 115 | MP0000249_abnormal_blood_vessel | 0.44315574 |
| 116 | MP0003941_abnormal_skin_development | 0.42537827 |
| 117 | * MP0000920_abnormal_myelination | 0.42336546 |
| 118 | MP0003436_decreased_susceptibility_to | 0.42207628 |
| 119 | MP0008873_increased_physiological_sensi | 0.42063949 |
| 120 | MP0002249_abnormal_larynx_morphology | 0.41860509 |
| 121 | MP0004883_abnormal_blood_vessel | 0.41714725 |
| 122 | * MP0003631_nervous_system_phenotype | 0.40801637 |
| 123 | MP0008874_decreased_physiological_sensi | 0.39543748 |
| 124 | MP0009115_abnormal_fat_cell | 0.39121320 |
| 125 | MP0005167_abnormal_blood-brain_barrier | 0.38812934 |
| 126 | MP0000003_abnormal_adipose_tissue | 0.38425684 |
| 127 | MP0003115_abnormal_respiratory_system | 0.38049157 |
| 128 | MP0002896_abnormal_bone_mineralization | 0.37840209 |
| 129 | * MP0003633_abnormal_nervous_system | 0.37026627 |
| 130 | MP0001243_abnormal_dermal_layer | 0.36696363 |
| 131 | MP0004272_abnormal_basement_membrane | 0.35729392 |
| 132 | MP0003953_abnormal_hormone_level | 0.35225712 |
| 133 | MP0001853_heart_inflammation | 0.34973215 |
| 134 | MP0002135_abnormal_kidney_morphology | 0.32895556 |
| 135 | MP0003566_abnormal_cell_adhesion | 0.31960612 |
| 136 | MP0002837_dystrophic_cardiac_calcinosis | 0.31545688 |
| 137 | MP0006035_abnormal_mitochondrial_morpho | 0.31414922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.52004376 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.15010795 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.92255799 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.54861300 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.33033466 |
| 6 | Xanthomatosis (HP:0000991) | 6.20697045 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.12787211 |
| 8 | Complement deficiency (HP:0004431) | 5.74459211 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.41399914 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.72089202 |
| 11 | Joint hemorrhage (HP:0005261) | 4.67914331 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.67279987 |
| 13 | Epidermoid cyst (HP:0200040) | 4.47778626 |
| 14 | Hyperammonemia (HP:0001987) | 4.38697590 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.34790032 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.24355173 |
| 17 | Abnormality of complement system (HP:0005339) | 4.19346330 |
| 18 | Hyperglycinemia (HP:0002154) | 4.11553294 |
| 19 | Fat malabsorption (HP:0002630) | 4.06893131 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.05160498 |
| 21 | Ketosis (HP:0001946) | 4.04314632 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.96163509 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 3.88934922 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.80854952 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.79500217 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.78431019 |
| 27 | Hyperglycinuria (HP:0003108) | 3.69459025 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.66251006 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.66251006 |
| 30 | Hypercholesterolemia (HP:0003124) | 3.60724626 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.52251923 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.35545619 |
| 33 | Myocardial infarction (HP:0001658) | 3.23197996 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.17079425 |
| 35 | Hepatocellular carcinoma (HP:0001402) | 3.15187491 |
| 36 | Spontaneous abortion (HP:0005268) | 3.14615622 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.11579870 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.09264560 |
| 39 | Steatorrhea (HP:0002570) | 3.05035080 |
| 40 | Vascular calcification (HP:0004934) | 3.03728165 |
| 41 | Purpura (HP:0000979) | 3.02238789 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.01849725 |
| 43 | Ketoacidosis (HP:0001993) | 2.97106379 |
| 44 | Skin nodule (HP:0200036) | 2.91354672 |
| 45 | Systemic lupus erythematosus (HP:0002725) | 2.87427140 |
| 46 | Gout (HP:0001997) | 2.86941729 |
| 47 | Delayed CNS myelination (HP:0002188) | 2.86935307 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 2.85001778 |
| 49 | Cardiovascular calcification (HP:0011915) | 2.82355190 |
| 50 | Osteomalacia (HP:0002749) | 2.79225151 |
| 51 | Abnormality of serum amino acid levels (HP:0003112) | 2.78791141 |
| 52 | Esophageal varix (HP:0002040) | 2.77405745 |
| 53 | Glomerulonephritis (HP:0000099) | 2.75719468 |
| 54 | Hypochromic microcytic anemia (HP:0004840) | 2.67441960 |
| 55 | Spastic diplegia (HP:0001264) | 2.60395638 |
| 56 | Mitral stenosis (HP:0001718) | 2.58378468 |
| 57 | Metabolic acidosis (HP:0001942) | 2.55626986 |
| 58 | Flat acetabular roof (HP:0003180) | 2.52054586 |
| 59 | Abnormality of carpal bone ossification (HP:0006257) | 2.50913365 |
| 60 | Amyloidosis (HP:0011034) | 2.45827039 |
| 61 | Abnormal tarsal ossification (HP:0008369) | 2.45613475 |
| 62 | Small epiphyses (HP:0010585) | 2.44605953 |
| 63 | Hypoglycemic seizures (HP:0002173) | 2.42342668 |
| 64 | Acanthocytosis (HP:0001927) | 2.41018439 |
| 65 | Lethargy (HP:0001254) | 2.38322428 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 2.32967808 |
| 67 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.32967808 |
| 68 | Abnormal gallbladder morphology (HP:0012437) | 2.32761495 |
| 69 | Gingival bleeding (HP:0000225) | 2.31631492 |
| 70 | Nephritis (HP:0000123) | 2.31166149 |
| 71 | Arthropathy (HP:0003040) | 2.28939856 |
| 72 | Cholelithiasis (HP:0001081) | 2.28100270 |
| 73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.27811059 |
| 74 | Malnutrition (HP:0004395) | 2.27415599 |
| 75 | Hemorrhage of the eye (HP:0011885) | 2.26134256 |
| 76 | Abnormal gallbladder physiology (HP:0012438) | 2.21076356 |
| 77 | Cholecystitis (HP:0001082) | 2.21076356 |
| 78 | Irritability (HP:0000737) | 2.19798235 |
| 79 | Neonatal onset (HP:0003623) | 2.19791072 |
| 80 | Menorrhagia (HP:0000132) | 2.16311784 |
| 81 | Sensorimotor neuropathy (HP:0007141) | 2.14429588 |
| 82 | Thrombophlebitis (HP:0004418) | 2.11528821 |
| 83 | Late onset (HP:0003584) | 2.11371159 |
| 84 | Facial shape deformation (HP:0011334) | 2.07862448 |
| 85 | Potter facies (HP:0002009) | 2.07862448 |
| 86 | Joint swelling (HP:0001386) | 2.03791880 |
| 87 | Pulmonary embolism (HP:0002204) | 2.01862536 |
| 88 | Enlarged kidneys (HP:0000105) | 2.01811380 |
| 89 | Cerebral edema (HP:0002181) | 2.01630295 |
| 90 | Pancreatitis (HP:0001733) | 2.01542244 |
| 91 | Rickets (HP:0002748) | 2.01142789 |
| 92 | Abnormal cartilage morphology (HP:0002763) | 1.98358961 |
| 93 | Abnormality of proline metabolism (HP:0010907) | 1.97473014 |
| 94 | Hydroxyprolinuria (HP:0003080) | 1.97473014 |
| 95 | Broad alveolar ridges (HP:0000187) | 1.95974290 |
| 96 | Abnormal delivery (HP:0001787) | 1.93540171 |
| 97 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.92972594 |
| 98 | Hypophosphatemic rickets (HP:0004912) | 1.89391142 |
| 99 | Increased purine levels (HP:0004368) | 1.89283011 |
| 100 | Hyperuricemia (HP:0002149) | 1.89283011 |
| 101 | Abnormality of the nasal septum (HP:0000419) | 1.88919529 |
| 102 | Bifid scrotum (HP:0000048) | 1.88413307 |
| 103 | Vomiting (HP:0002013) | 1.88285075 |
| 104 | Abnormal hand bone ossification (HP:0010660) | 1.86475519 |
| 105 | Abnormality of the gallbladder (HP:0005264) | 1.85821182 |
| 106 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83837140 |
| 107 | Generalized aminoaciduria (HP:0002909) | 1.83193716 |
| 108 | Epistaxis (HP:0000421) | 1.82661828 |
| 109 | Opisthotonus (HP:0002179) | 1.82364915 |
| 110 | Brushfield spots (HP:0001088) | 1.82237764 |
| 111 | Hyperglycemia (HP:0003074) | 1.79047175 |
| 112 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.78979206 |
| 113 | Poikilocytosis (HP:0004447) | 1.78202917 |
| 114 | Right ventricular cardiomyopathy (HP:0011663) | 1.75917927 |
| 115 | Abnormal ossification of hand bones (HP:0005921) | 1.75360102 |
| 116 | Epiphyseal dysplasia (HP:0002656) | 1.73609613 |
| 117 | Stroke (HP:0001297) | 1.70931875 |
| 118 | Hypertriglyceridemia (HP:0002155) | 1.70923573 |
| 119 | Broad palm (HP:0001169) | 1.70250994 |
| 120 | Back pain (HP:0003418) | 1.70249587 |
| 121 | Elevated hepatic transaminases (HP:0002910) | 1.67874203 |
| 122 | Hepatoblastoma (HP:0002884) | 1.67686201 |
| 123 | Glomerulosclerosis (HP:0000096) | 1.65339256 |
| 124 | Arterial tortuosity (HP:0005116) | 1.64922173 |
| 125 | Increased serum pyruvate (HP:0003542) | 1.64468679 |
| 126 | Neoplasm of the liver (HP:0002896) | 1.63848340 |
| 127 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.62546339 |
| 128 | Fair hair (HP:0002286) | 1.61443198 |
| 129 | Vaginal fistula (HP:0004320) | 1.56927412 |
| 130 | Peritonitis (HP:0002586) | 1.56381864 |
| 131 | Focal segmental glomerulosclerosis (HP:0000097) | 1.55977625 |
| 132 | Abnormality of the Achilles tendon (HP:0005109) | 1.55277898 |
| 133 | Hypothermia (HP:0002045) | 1.54591847 |
| 134 | Abnormal foot bone ossification (HP:0010675) | 1.53074645 |
| 135 | Pigmentary retinal degeneration (HP:0001146) | 1.52679362 |
| 136 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.50864233 |
| 137 | Abnormality of the lumbar spine (HP:0100712) | 1.48171080 |
| 138 | Papillary thyroid carcinoma (HP:0002895) | 1.47251755 |
| 139 | Abnormality of the acetabulum (HP:0003170) | 1.46312585 |
| 140 | Abnormality of the wing of the ilium (HP:0011867) | 1.46106340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.41319223 |
| 2 | SIK1 | 4.52306320 |
| 3 | FGFR4 | 4.17710406 |
| 4 | ERN1 | 4.04498295 |
| 5 | ICK | 2.90833921 |
| 6 | EPHA2 | 2.65346161 |
| 7 | WNK4 | 2.57709894 |
| 8 | INSRR | 2.54137866 |
| 9 | ERBB4 | 2.53879656 |
| 10 | MST1R | 2.46332127 |
| 11 | CDK12 | 2.45915038 |
| 12 | TAOK3 | 2.30608339 |
| 13 | LATS1 | 2.30105863 |
| 14 | TRIB3 | 2.28289770 |
| 15 | FRK | 2.28064474 |
| 16 | PKN2 | 2.22486353 |
| 17 | PTK6 | 2.01066655 |
| 18 | NEK9 | 1.77982567 |
| 19 | EPHB1 | 1.68494582 |
| 20 | AKT3 | 1.60815614 |
| 21 | TYK2 | 1.56415468 |
| 22 | MAP2K4 | 1.53130209 |
| 23 | FGFR2 | 1.49723106 |
| 24 | TYRO3 | 1.44660841 |
| 25 | RIPK1 | 1.43288440 |
| 26 | TGFBR2 | 1.42260092 |
| 27 | PIK3CG | 1.41451203 |
| 28 | DAPK2 | 1.41109019 |
| 29 | FLT3 | 1.40476706 |
| 30 | EPHA3 | 1.40089743 |
| 31 | CAMK1D | 1.39641232 |
| 32 | MAPK11 | 1.37704671 |
| 33 | WNK1 | 1.37260114 |
| 34 | FER | 1.35212609 |
| 35 | BRSK2 | 1.33921302 |
| 36 | STK39 | 1.30509184 |
| 37 | MAPKAPK3 | 1.22527101 |
| 38 | NLK | 1.18885664 |
| 39 | PTK2 | 1.16002906 |
| 40 | MAP3K7 | 1.14589237 |
| 41 | ERBB2 | 1.13811512 |
| 42 | ABL2 | 1.13736028 |
| 43 | JAK1 | 1.13368980 |
| 44 | MET | 1.12997387 |
| 45 | SGK223 | 1.10078269 |
| 46 | SGK494 | 1.10078269 |
| 47 | KDR | 1.09834628 |
| 48 | JAK2 | 1.06244656 |
| 49 | PRKAA2 | 1.05733157 |
| 50 | MAP3K3 | 1.04778260 |
| 51 | BCR | 1.04316118 |
| 52 | EEF2K | 1.03901910 |
| 53 | CDK6 | 1.02551054 |
| 54 | CAMK1G | 1.00791668 |
| 55 | TBK1 | 0.96932601 |
| 56 | EIF2AK1 | 0.96501525 |
| 57 | TIE1 | 0.88343016 |
| 58 | NTRK1 | 0.87891584 |
| 59 | FGFR3 | 0.87783435 |
| 60 | STK38L | 0.87595305 |
| 61 | PDGFRA | 0.87386561 |
| 62 | SGK2 | 0.85272237 |
| 63 | NTRK3 | 0.82476757 |
| 64 | PDK1 | 0.80334600 |
| 65 | CDC42BPA | 0.80280817 |
| 66 | DYRK1B | 0.78984686 |
| 67 | SGK1 | 0.78836704 |
| 68 | CSNK1E | 0.78273942 |
| 69 | GSK3A | 0.78168837 |
| 70 | MAP3K14 | 0.75226997 |
| 71 | PIK3CA | 0.74232756 |
| 72 | CSK | 0.74083240 |
| 73 | PAK3 | 0.73037759 |
| 74 | MAP2K1 | 0.72342892 |
| 75 | MAPK15 | 0.71646585 |
| 76 | MAP2K3 | 0.71518385 |
| 77 | PRKCZ | 0.70317936 |
| 78 | SIK2 | 0.69600512 |
| 79 | BMX | 0.67094696 |
| 80 | MAP3K2 | 0.66582123 |
| 81 | CAMK2G | 0.66499360 |
| 82 | RPS6KB1 | 0.65901348 |
| 83 | EPHB2 | 0.65897586 |
| 84 | LMTK2 | 0.63024959 |
| 85 | MAPK4 | 0.61342805 |
| 86 | MAP3K10 | 0.60378599 |
| 87 | MAP2K2 | 0.60285977 |
| 88 | NEK6 | 0.58886251 |
| 89 | CDK8 | 0.58275901 |
| 90 | PRKACG | 0.56785972 |
| 91 | STK38 | 0.55736016 |
| 92 | RET | 0.55277946 |
| 93 | IGF1R | 0.54525322 |
| 94 | EPHA4 | 0.53776224 |
| 95 | SGK3 | 0.53135420 |
| 96 | MARK2 | 0.51490881 |
| 97 | PINK1 | 0.51177501 |
| 98 | GRK6 | 0.51119048 |
| 99 | STK3 | 0.50605501 |
| 100 | PRKAA1 | 0.48907830 |
| 101 | YES1 | 0.48217565 |
| 102 | ZAP70 | 0.48058977 |
| 103 | TTN | 0.48044672 |
| 104 | SRC | 0.47701592 |
| 105 | EGFR | 0.47551386 |
| 106 | FGR | 0.46946459 |
| 107 | KSR2 | 0.46669969 |
| 108 | MAPK12 | 0.46347862 |
| 109 | CSNK1G1 | 0.45877206 |
| 110 | GRK1 | 0.45512597 |
| 111 | MELK | 0.42708772 |
| 112 | PDPK1 | 0.42644618 |
| 113 | MTOR | 0.42580915 |
| 114 | BRSK1 | 0.41688636 |
| 115 | MYLK | 0.41426556 |
| 116 | IKBKE | 0.40960562 |
| 117 | PDK4 | 0.40304099 |
| 118 | PDK3 | 0.40304099 |
| 119 | LRRK2 | 0.40125622 |
| 120 | FGFR1 | 0.39410225 |
| 121 | PRKG1 | 0.38320189 |
| 122 | MAP3K1 | 0.37322071 |
| 123 | CHUK | 0.37026154 |
| 124 | ABL1 | 0.36486765 |
| 125 | CAMKK2 | 0.35344308 |
| 126 | RPS6KA3 | 0.34113530 |
| 127 | IRAK3 | 0.33610334 |
| 128 | MAP3K11 | 0.33541266 |
| 129 | PDGFRB | 0.33398787 |
| 130 | LATS2 | 0.32723730 |
| 131 | CSF1R | 0.32605990 |
| 132 | PRKD1 | 0.32526944 |
| 133 | MATK | 0.31884661 |
| 134 | SCYL2 | 0.31822009 |
| 135 | PRKACB | 0.31257748 |
| 136 | PAK4 | 0.30866607 |
| 137 | MAP3K6 | 0.30828550 |
| 138 | CSNK1D | 0.30394787 |
| 139 | PRKCQ | 0.29892929 |
| 140 | CDK9 | 0.29855050 |
| 141 | MAP2K6 | 0.29178827 |
| 142 | TRPM7 | 0.28473670 |
| 143 | MAPK7 | 0.28472491 |
| 144 | CSNK1A1L | 0.27536880 |
| 145 | IRAK1 | 0.25278486 |
| 146 | DDR2 | 0.24535799 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.42146530 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.75609415 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.32632321 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.24463854 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.00699209 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.92826965 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68249923 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64958289 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57569761 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.52376172 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.38108132 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34520300 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.23341363 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.16986705 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.06183487 |
| 16 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.04459302 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.04439469 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.04208038 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.97613905 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94430823 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.91938266 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.91708386 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.87535039 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.85520319 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82655688 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68600898 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68588047 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.65022717 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.60118038 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.57864856 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56570875 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.52626573 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49633209 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48421357 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46698230 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43432566 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39042016 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34391161 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30055149 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26252566 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26029291 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.20862515 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18658691 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17358021 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13014622 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11397512 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08273555 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.04396120 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98378977 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.91756951 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89839951 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88395893 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88202710 |
| 54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.87222658 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86926804 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85778419 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82326560 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80766113 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.80434945 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75614660 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70613258 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68779523 |
| 63 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67160336 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.59496791 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58319267 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50524530 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49083228 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.40611572 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37788529 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36605785 |
| 71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.36547957 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31642206 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.31442882 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.27525096 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25241629 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21708239 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19467367 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.18684105 |
| 79 | Circadian rhythm_Homo sapiens_hsa04710 | 0.16822406 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.16635436 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10906847 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10898048 |
| 83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.09359057 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08227178 |
| 85 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.07971780 |
| 86 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.00319010 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.00285236 |
| 88 | Adherens junction_Homo sapiens_hsa04520 | -0.2004826 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1853138 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1778625 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1746338 |
| 92 | Malaria_Homo sapiens_hsa05144 | -0.1530126 |
| 93 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1485519 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1338189 |
| 95 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1306279 |
| 96 | Pertussis_Homo sapiens_hsa05133 | -0.1301559 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1300746 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1266400 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1196388 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1098327 |
| 101 | Lysosome_Homo sapiens_hsa04142 | -0.0960536 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | -0.0699465 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0678791 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | -0.0586474 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0568334 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0499932 |
| 107 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0359213 |
| 108 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0310902 |

